More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

While Sanofi’s immunology megablockbuster Dupixent predictably dominated the company’s sales charts in 2024, a new golden ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

The Health Protection Surveillance Centre (HPSC) has reported a further reduction in cases of flu, the Respiratory Syncytial ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw ...

The Cyprus pulmonology society on Thursday urged Health Minister Michael Damianos to approve a respiratory syncytial virus ...

Lower rates of both progression of macular fibrosis and intravitreal aflibercept injections were found in those who used the ...

Corewell Health Helen DeVos Children’s Hospital will be limiting the number of visitors in their pediatric areas due to an i ...

Wales is past the peak of its flu season according to public health bosses. Cases of flu have caused chaos in Wales' ...

Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.

Moving on to the common cold, caused by the rhinovirus, the UKHSA explains that symptoms develop gradually over a few days.